akshay jadhav

According to the new market research report "Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022", published by MarketsandMarkets™, The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022. Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=170644018

According to the new market research report "Health Information Exchange Market by Set Up Type (Public, Private), Type (Pull, Push), Implementation Model (Federated, Hybrid), Application (Web Portal, Secure Messaging), Solution Type (Portal, Platform Centric), & End Users - Global Forecast to 2020", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, opportunities, key players, competitive landscape, and geographical markets.

According to the new market research report “Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", published by MarketsandMarkets™, The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.

The report "Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), & by Test (In Vitro, LAL, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, opportunities, current market trends, and strategies impacting the global pyrogen testing market along with the estimates and forecasts of the revenue and market share analysis.

According to the new market research report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Re moval, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023", published by MarketsandMarkets™, The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.

According to the new market research report “Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021", published by MarketsandMarkets™, The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.

The report "Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) - Global Forecast to 2020", The global Walking Assist Devices Market report defines and segments the walking assist devices market globally with analysis and forecast of revenue. The global walking assist devices market is expected to reach USD 6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

The report "Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the vaccine adjuvants market along with the estimates and forecasts of the revenue and market share analysis.

According to the new market research report “Genotyping Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, The genotyping assay market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.

According to the new market research report “HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020", published by MarketsandMarkets™, provides a detailed overview of the major drivers, restraints, opportunities, challenges, current market trends, and strategies impacting the market along with estimates and forecasts of revenue.

According to the new market research report “Western Blotting Market by Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) - Global Forecasts to 2021", published by MarketsandMarkets™, This report studies the global western blotting market for the forecast period of 2016 to 2021. This market is expected to reach USD 730.7 Million by 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9 %. The global western blotting market is segmented on the basis of product, application, end user and region.

According to the new market research report “Pedicle Screw System Market by Product Type (Monoaxial & Polyaxial Pedicle Screw), Surgery (Open Surgery, Minimal Invasive Surgery), Indication (Spinal Deformities, Spinal Trauma), Application (Thoracolumbar, Cervical Fusion) - Global Forecast to 2023", published by MarketsandMarkets™, The pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%.

According to the new market research report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023", published by MarketsandMarkets™, The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.

According to the new market research report “Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023", published by MarketsandMarkets™, The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

The global clinical chemistry analyzer market was valued at $8,965.00 million in 2014 and is poised to grow at a CAGR of 5.52% between 2014and 2019, to reach $11,728.01 million in 2019. Rapid growth in the diagnostics market, increase in the healthcare spending, and increasing incidence in lifestyle disease will drive the growth of the market. Furthermore, increasing awareness for preventative healthcare, increase in aging population, increase in reagent rental agreements and increasing demand for laboratory automation will aid the demand for clinical chemistry analyzer products. This report segment the clinical chemistry analyzer market on the basis of products, test, end users and regions. The product segments included in this report are analyzers, reagents and other products. The clinical chemistry analyzer product segment is further divided on the basis of type into four segments, Small (400-800 Test/H), Medium (800-1,200 Tests/H), Large (1,200-2,000 Tests/H), Very large (2,000 Tests/H). The reagents product segment is further categorized into calibrators, controls, standards and other reagents. The tests segments included in this report are basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. The end-user segments included in this report are academic research institutes, diagnostic laboratories, hospitals, and other end users. The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW). The geographic analysis reveals that Americas accounted for the largest share in the global market in 2014. The BRIC regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing demand for automation from this region. The major players in the market include Roche Diagnostics (Switzerland), Beckman Coulter (U.S.) Abbott Diagnostics (U.S.) Siemens AG (Germany), Ortho-Clinical Diagnostics (U.S.), Thermo Fisher Scientific(U.S.) Randox Laboratories Ltd. (U.K.), ElitechGroup(France), Mindray (China), Horiba (Japan).

Medical document management systems have gained remarkable importance in the healthcare industry over the past few years. The global Medical Document Management Systems Market is estimated to be worth around $220 Million in 2014 and $424.5 Million by 2019. The medical document management systems market is poised to grow at a 13% - 14% CAGR during the next five years, driven by factors such as the need to reduce healthcare costs, ensure regulatory compliance, and improve clinical efficiency and patient care. The market has reaped significant opportunities from the healthcare sector, mainly because of this sector’s paper-intensive nature, and its need for efficient management of information while ensuring security and privacy. Primary factors responsible for the growth of this market are the need for electronic document management with the increasing adoption of EMR systems & HIM systems, and the need to retain patient data securely according to state, federal and local laws. Moreover, a lot of data is being generated due to the increasing number of patients being treated and the rising number of medical facilities. Management of this data and the need to minimize the use of paper to reduce operational costs and storage issues is also driving the market for medical document management systems. However, the high costs of implementation, confidentiality concerns, and the reluctance of medical, nursing, and other staff to change their traditional ways are restricting the growth of this market to a certain extent. Geographically, North America dominates market, mainly due to the presence of regulations such as HIPPA and ARRA. Factors such as the need for cost containment in healthcare and to improve patient care are further propelling market growth in this region. There are number of small and mid-size players specialized in this market which intensifies competition and thus poses a challenge to big players and new entrants. In order to increase their market share, mid-size and small players are continuously upgrading existing products and launching new ones, while the big players are acquiring small firms to expand and strengthen their product portfolios. Prominent players in the global medical document management systems market are McKesson Corporation (U.S.), 3M Company (U.S.), Siemens Medical Solutions USA, Inc. (U.S.), GE Healthcare (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Toshiba Medical systems Corporation (Japan), Cerner Corporation (U.S.), Kofax Ltd. (U.S.), EPIC Systems (U.S.), and Hyland Software (U.S.).

The global soft tissue repair market is estimated to grow at a CAGR of 7.5% from 2014 to 2019 to reach $14.7 billion in 2019. The increasing incidence of soft tissue injuries among the active aging population, increasing participation in sports, increasing obesity rate, and increasing healthcare expenditure & lack of substitutes for soft tissue repair surgery are the major factors driving market growth. The soft tissue repair market is witnessing a gradual shift towards biological meshes from conventional synthetic meshes for soft tissue repair. Such products offer enhanced biocompatibility, strength, and improved aesthetics. However, the high costs of surgical procedures, and the lack of reimbursement are some major factors that could hinder the growth of this market to a certain extent. The market studied in this report is mainly segmented by products and applications. Based on products, the market is segmented into tissue patch/mesh, soft tissue fixation devices, and laparoscopic instruments. On the basis of application, the market is segmented into hernia repair, dural repair, vaginal sling procedure, skin repair, orthopedic and dental repair, and breast reconstruction repair. The global market is dominated by North America, followed by Europe. The Asia-Pacific market is expected to witness the highest growth due to the increasing demand for tissue regeneration & orthopedic soft tissue repair procedures (caused by the huge aging population and the rising number of patients with soft tissue injuries). North America and Europe are expected to grow at a sluggish rate since these are relatively saturated markets. Prominent players in this market are LifeCell Corporation (U.S.), Organogenesis (U.S.), C.R. Bard, Inc. (U.S.), Johnson & Johnson (U.S.), Covidien plc (Ireland), Arthrex, Inc. (U.S.), Smith & Nephew plc (U.K.), Integra Lifesciences Corporation (U.S.), Wright Medical Technology (U.S.), and Stryker Corporation (U.S.).

The fetal monitoring market is expected to reach $2,346.4 million by 2019 from $1,688.7 million in 2014, at a CAGR of 6.8%. Major factors driving the growth of this market include increasing initiatives from government and non-government bodies for improving maternal/fetal health across the globe, rising company investments in the development of fetal monitors, increasing number of conferences and symposia, and technological advancements. However, high cost of equipment and stringent regulatory procedures are expected to restrain the growth of this market. Emerging economies such as India and China present an array of opportunities for the growth of this market. North America dominated the global market, with the U.S. accounting for a major market share. However, Asia is poised to grow at the highest CAGR during the forecast period, owing to government initiatives, rising focus of major market players on the Indian market, and increasing birth rate in this region. Prominent players in the fetal monitoring market are Analogic Corporation (U.S.), ArjoHuntleigh, Inc. (U.S.), Covidien PLC (U.S.), FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), and Spacelabs Healthcare, Inc. (U.S.).

The western blotting market is expected to reach USD 730.7 Million in 2021 from USD 574.8 Million in 2016, growing at a CAGR of 4.9%. Increasing number of research activities and R&D spending by pharmaceutical and biotechnology companies, rising prevalence of HIV/AIDS, growing proteomics market, growing number of industry-academic research collaborations, increasing demand for personalized medicine, and new product launches are expected to drive the growth of the market in the coming years. The global market is segmented on the basis of product, application, and end user. By product, the market is categorized into consumables and instruments. The consumables segment is estimated to account for the largest share of the global market, by product in 2016. The western blotting instruments segment is segmented into gel electrophoresis instruments, blotting systems, and imagers. The blotting systems segment is expected to account for the largest share of the instruments market, by type in 2016 and is expected to grow at the highest CAGR during the forecast period (2016-2021). The western blotting consumables segment is further segmented into reagents, kits, and others (transfer membranes, blotting papers, primary & secondary antibodies, and gels, among others). Based on the applications, the global western blotting market is segmented into biomedical & biochemical research, disease diagnostics, agriculture, and others (quality control and biologics). The biomedical & biochemical research segment is expected to account for the largest share of the global market, by application in 2016. However, the disease diagnostics segment is projected to grow at the highest CAGR from 2016 to 2021, owing to increasing diagnosis, incidences, and prevalence of HIV, HSV, HBV, Lyme disease, and mad cow’s disease among others. The western blotting market, by end user is segmented into academic & research institutes, pharmaceutical & biotechnology companies, diagnostic centers, and others (CROs, food & beverage companies, and forensic laboratories). The academic & research institutes segment is expected to command the largest share of the global market, by end user in 2016. However, the diagnostic centers segment is projected to grow at the highest CAGR from 2016 to 2021.

The global genotyping market is expected to reach $17.0 Billion in 2020 from $6.2 Billion in 2015, at a CAGR of 22.3% during the forecast period of 2015 to 2020. Market growth will be attributed to the availability of a range of products for wide applications, decreasing prices of DNA sequencing, increasing incidence of and awareness on genetic diseases and personalized medicine, increasing demand for pharmacogenomics in drug discovery and development, and the rising use of genetic analysis of animal and plant livestock. The genotyping market studied in this report is mainly segmented by product, technology, applications, and end user. The market, by product & services, is segmented into instruments (sequencers & amplifiers, and analyzers), reagents and kits, bioinformatics software and services. Reagents & kits market is expected to grow at a CAGR of during the forecast period of 2015 to 2020. Based on application, the market is segmented into pharmacogenomics, diagnostic research, animal genetics, agricultural biotechnology, and others (prenatal testing, parental testing, forensics, and microbial genotyping). The pharmacogenomics segment is expected to grow at a highest CAGR of 23.4% during the forecast period. The market, by technology, is segmented into microarray, capillary electrophoresis, polymerase chain reaction (PCR), sequencing, MALDI-TOF, and others (allele specific oligonucleotide (ASO) probes, & in situ hybridization). Sequencing is the high growth market, owing to its widening application areas of DNA sequencing technologies, technological advancements, and the availability of high-speed sequencing instruments are expected to contribute to the growth of the DNA sequencing market in the coming years. Developed geographies like North America and Europe are saturated markets and expected to grow at a slower rate, whereas the Asian market is expected to witness the highest growth of CAGR, 25.4% from 2015 to 2020, due to the huge demand for better healthcare services, expanding per capita income, increasing ongoing clinical trials in these regions, and the increasing focus of leading players on these regions. The key players operating in genotyping market are Affymetrix, Inc. (U.S.), Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies (U.S.), Beckman Coulter (U.S.), Sequenom, Inc. (U.S.), Roche (Switzerland), GE Healthcare (U.K.), and Fluidigm Corporation (U.S.)

The report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the varicose vein treatment market in North America and Europe along with the estimates and forecasts of the revenue and market share analysis. The varicose vein treatment market is poised to witness a steady growth between 2016 and 2021. Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, huge burden of varicose vein cases in North America and Europe, improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population will majorly drive the varicose vein treatment market. This report broadly segments the varicose vein treatment market into mode of treatment and products. The varicose vein treatment market, by products is segmented into ablation devices, venous closure products, and surgical products. The ablation devices segment is further categorized into radiofrequency ablation devices and laser ablation devices. On the basis of mode of treatment, the varicose vein treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. This report covers the varicose vein treatment market across two major geographies, namely, North America and Europe. In this report, the North American varicose vein treatment market is further segmented into the U.S. and Canada, while the European varicose vein treatment market is categorized into Germany, U.K., France, Italy, Spain, and Rest of Europe. In 2016, North America is expected to command the largest share of the varicose vein treatment market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region. Medtronic plc (Ireland); AngioDynamics, Inc. (U.S.); biolitec AG (Austria); Syneron Medical Ltd. (Israel); Lumenis Ltd. (Israel); Dornier MedTech GmbH (Germany); Energist Group (U.K.); Eufoton s.r.l. (Italy); Vascular Solutions, Inc. (U.S.); Quanta System S.p.A. (Italy); Sciton, Inc. (U.S.); Fotona d.o.o. (Slovenia); BTG plc (U.K.); and Merz Aesthetics (U.S.) are the key players in the varicose vein treatment market.

The global synthetic biology market is projected to reach USD 8.84 Billion by 2022 from USD 3.57 Billion in 2017, at a CAGR of 19.9%. This high growth rate can be attributed to the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. Factors such as rising concerns regarding fuel consumption and increasing demand for protein therapeutics are expected to offer lucrative opportunities for players in the global market. In this report, the global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes. By technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the global market in technology. This is attributed to the fact that the technology is used in a wide range of applications such as producing vaccines, engineering enzymes to restrict cancer growth, producing sustainable biofuels, improving crop yield, and detecting and breaking down environmental pollutants in the soil, air, and water offered by gene synthesis.

The global synthetic biology market is projected to reach USD 8.84 Billion by 2022 from USD 3.57 Billion in 2017, at a CAGR of 19.9%. This high growth rate can be attributed to the wide range of applications of synthetic biology, rising R&D funding and initiatives, increasing demand for synthetic genes and synthetic cells, and increasing investments in synthetic biology companies. Factors such as rising concerns regarding fuel consumption and increasing demand for protein therapeutics are expected to offer lucrative opportunities for players in the global market. In this report, the global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. In 2017, oligonucleotides are expected to account for the largest share of the global market owing to the large-scale production of modified oligonucleotides for next-generation sequencing and the increasing market demand for synthetic genes. By technology, the synthetic biology market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology. In 2017, the gene synthesis segment is expected to account for the largest share of the global market in technology. This is attributed to the fact that the technology is used in a wide range of applications such as producing vaccines, engineering enzymes to restrict cancer growth, producing sustainable biofuels, improving crop yield, and detecting and breaking down environmental pollutants in the soil, air, and water offered by gene synthesis.

Elemental analysis helps in quantitative and qualitative identification of various elements in different application areas such as life sciences, food and beverage testing, environment testing, geology, cosmetics testing, and petroleum. The technologies used for elemental analysis depend on the sample to be analyzed. The technologies predominantly used for elemental analysis are Inductively Coupled Plasma Spectrometry, Inductively Coupled Plasma-Mass Spectrometry (ICP-MS), Inductively Coupled Plasma-Optical Emission Spectrometry (ICP-OES), X-ray Diffraction (XRD), and X-ray Fluorescence (XRF). Both organic and inorganic elements can be identified using these technologies. The global market is segmented on the basis of types, technologies, and applications. By type, the market is categorized into organic elemental analysis and inorganic elemental analysis. In 2015, the inorganic elemental analysis segment is estimated to account for the larger share of the market. This segment is expected to grow at the higher rate during the forecast period. On the basis of technology, the market is divided into destructive and nondestructive technologies. In 2015, the nondestructive technologies segment is likely to account for the larger share of the market. However, the destructive technologies segment is expected to grow at the higher rate from 2015 to 2020. The market, by application, is segmented into life sciences, food and beverage testing, environment testing, geology, and other application areas. In 2015, the environment testing segment is poised to account for the largest share of the market. However, the life sciences segment is expected to grow at the fastest rate during the forecast period. The key factors that are expected to spur the growth of this market are the increasing use of X-ray fluorescence in medical research, growing food safety concerns, and increasing life science R&D spending. Moreover, emerging nations of India and China, increasing demand from applied markets, and requirement to comply with the revised chapter 231 of the U.S. Pharmacopeia are likely to create opportunities for elemental analyzers. However, high cost of elemental analysis equipment is likely to pose as a restraint for the growth of this market. Need for highly skilled professionals acts as a challenge in the global market